Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Clinical Cancer Research

• Publication date

  1996-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9816130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma

  2005cited by this paper
• DETECTION OF p53 AND bcl‐2 PROTEIN IN CARCINOMA OF THE RENAL PELVIS AND URETER INCLUDING DYSPLASIA

  1996cited by this paper
• Abundance and subcellular localisation of cyclin D3 in human tumours

  1996cited by this paper
• Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma.

  1995cited by this paper
• Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.

  1995cited by this paper
• Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.

  1995cited by this paper
• D-type cyclins.

  1995cited by this paper
• Alternate splicing produces a novel cyclin D1 transcript.

  1995cited by this paper
• Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines.

  1994cited by this paper
• P53 protein expression and prognosis in squamous cell carcinoma of the esophagus

  1994cited by this paper
• PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.

  1994cited by this paper
• Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

  1994cited by this paper
• Cyclin E, a potential prognostic marker for breast cancer.

  1994cited by this paper
• Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.

  1993cited by this paper
• Redundant cyclin overexpression and gene amplification in breast cancer cells.

  1993cited by this paper
• Prognostic significance of human papillomavirus genomes (type‐16, ‐18) and aberrant expression of p53 protein in human esophageal cancer

  1993cited by this paper
• Amplification of cyclin genes in colorectal carcinomas.

  1993cited by this paper
• Expression and amplification of cyclin genes in human breast cancer.

  1993cited by this paper
• Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma

  1992cited by this paper
• Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma.

  1992cited by this paper
• Interaction between human cyclin A and adenovirus E1A-associated p107 protein.

  1992cited by this paper
• Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins.

  1992cited by this paper
• Amplification and expression of the human cyclin D gene in esophageal cancer.

  1992cited by this paper
• Cyclin A is required at two points in the human cell cycle.

  1992cited by this paper
• A novel cyclin encoded by a bcl1-linked candidate oncogene

  1991cited by this paper
• Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.

  1991cited by this paper
• Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.

  1991cited by this paper
• Human D-type cyclin.

  1991cited by this paper
• Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast.

  1991cited by this paper
• Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

  1991cited by this paper
• D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.

  1991cited by this paper
• Cyclins and cancer.

  1991cited by this paper
• Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma

  1990cited by this paper
• Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2.

  1989cited by this paper

• Prognostic Biomarkers in Pituitary Tumours: A Systematic Review

  2023cites this paper
• Inhibitory Effects of Rabdosia rubescens in Esophageal Squamous Cell Carcinoma: Network Pharmacology and Experimental Validation

  2022cites this paper
• Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities

  2022cites this paper
• Cyclin A in nonfunctioning pituitary adenomas

  2020cites this paper
• Network-based meta-analysis for the identification of potential target for human anaplastic thyroid carcinoma

  2020cites this paper
• MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2

  2019cites this paper
• Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo

  2019cites this paper
• Development of fluorescent biosensors and inhibitors to probe and target CDK5/p25 in glioblastoma

  2016cites this paper
• Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.

  2016cites this paper
• Prognostic markers in rectal neuroendocrine tumors

  2015cites this paper
• Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors

  2015cites this paper
• Cyclin A predicts metastatic potential of rectal neuroendocrine tumors.

  2014cites this paper
• Reduced graphene oxide upconversion nanoparticle hybrid for electrochemiluminescent sensing of a prognostic indicator in early-stage cancer.

  2014cites this paper
• Overexpression of cyclin A in oral dysplasia: An international comparison and literature review.

  2014cites this paper
• Direct progression of capsular invasive carcinomas from subcapsular focal hyperplasias induced by hypothyroidism-mediated tumor promotion in a rat two-stage thyroid carcinogenesis model

  2013cites this paper
• poor outcome in T4 esophageal squamous cell carcinoma Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict

  2013cites this paper
• The Role of Glycogen Synthase Kinase 3-β in Immunity and Cell Cycle: Implications in Esophageal Cancer

  2013cites this paper
• Expression of cyclins A and E in melanocytic skin lesions and its correlation with some clinicopathologic features.

  2012cites this paper
• A functional single nucleotide polymorphism at the promoter region of cyclin A2 is associated with increased risk of colon, liver, and lung cancers

  2011cites this paper
• Prognostic significance of cyclooxygenase-2 and associated molecules in gastric cancer

  2011cites this paper
• Expression and prognostic significance of cyclin B1 and cyclin A in non‐small cell lung cancer

  2009cites this paper
• Differences in Protein Expression and Gene Amplification of Cyclins between Colon and Rectal Adenocarcinomas

  2009cites this paper
• IMMUNOHISTOCHEMICAL EXPRESSION OF PROTEIN p16 IN WILMS' TUMOR

  2008cites this paper
• Immunohistochemical Detection of Cyclin A in Wilms Tumor

  2008cites this paper
• Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways

  2006cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 147 Predictive Factors in Esophageal Carcinoma

  2006cites this paper
• Prognostic significance of cyclin A in gastric cancer

  2006cites this paper
• Predictive factors in esophageal carcinoma.

  2006cites this paper
• Relationship between proliferative activity of cancer cells and clinicopathological factors in patients with esophageal squamous cell carcinoma.

  2005cites this paper
• Cyclins D1, D3, E, and A in vulvar carcinoma patients.

  2005cites this paper
• Expression of cyclin A in Merkel cell carcinoma

  2004cites this paper
• Prognostic factors in primary merkel cell carcinoma

  2004cites this paper
• Clinicopathologic significance of cyclin A expression in colorectal carcinoma.

  2004cites this paper
• Overexpression of cyclins A and B as markers of neoplastic glandular lesions of the cervix.

  2004cites this paper
• Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan.

  2003cites this paper
• Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.

  2003cites this paper
• Cdc2 expression in primary thyroid lymphoma: its relationship with biological aggressiveness and G2 cyclins.

  2003cites this paper
• p34cdc2 expression is an independent indicator for lymph node metastasis in colorectal carcinoma

  2003cites this paper
• Expression of the G2-M Modulators in Pancreatic Adenocarcinoma

  2002cites this paper
• Cyclin A in cell cycle control and cancer

  2002cites this paper
• 10 Roles of immunohistochemical expression of cyclin A and cyclin-dependent kinase 2 in colorectal tumors

  2002cites this paper
• Cyclin A expression in superficial squamous cell carcinoma of the esophagus and coexisting infiltrated lymphocyte follicle.

  2002cites this paper
• Cyclin A correlates with carcinogenesis and metastasis, and p27(kip1) correlates with lymphatic invasion, in colorectal neoplasms.

  2002cites this paper
• Clinicopathological significance of pRb2/p130 expression in squamous cell carcinoma of the esophagus

  2002cites this paper
• Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables

  2002cites this paper
• Aberrant expression of cyclin A in laryngeal squamous cell carcinoma.

  2002cites this paper
• Expression of G2-M modulators in thyroid neoplasms: correlation of cyclin A, B1 and cdc2 with differentiation.

  2002cites this paper
• Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome

  2001cites this paper
• Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict poor outcome in T4 esophageal squamous cell carcinoma.

  2000cites this paper
• Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array

  2000cites this paper
• Expression and Prognostic Role of Cyclin-Dependent Kinase 1 (cdc2) in Hepatocellular Carcinoma

  2000cites this paper
• Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.

  2000cites this paper
• Amplification of the cyclin A gene in canine and feline mammary tumors.

  2000cites this paper
• Positive correlation between p27[KIP1] expression and progression of human esophageal squamous cell carcinoma

  2000cites this paper
• Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland

  2000cites this paper
• Aberrant expression of cyclin A in head and neck cancer

  2000cites this paper
• Overexpression of cyclin A and cyclin B1 proteins in astrocytomas.

  2000cites this paper
• Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma

  1999cites this paper
• Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma

  1999cites this paper
• Positive correlation between P27Kip1 expression and progression of human esophageal squamous cell carcinoma

  1998cites this paper
• Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma.

  1998cites this paper
• Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.

  1998cites this paper
• Biology of esophageal cancer and the role of combined modality therapy.

  1997cites this paper